Carrie Liao Biography and Net Worth

Carrie Liao, CPA is an active Certified Public Accountant in the state of California with over 20 years of accounting and finance leadership experience in public and private companies. Starting at Deloitte, her career has focused on the life science industry from early development through commercialization and manufacturing. Recently, she has successfully supported multiple Initial Public Offering filings. She specializes in Sarbanes-Oxley Act compliance, resolution of complex accounting issues, process improvement, and U.S. Securities and Exchange Commission interim and annual filings. Prior to joining MindMed, Ms. Liao was the Corporate Controller at ORIC Pharmaceuticals, a public clinical stage biopharmaceuticals company (NASDAQ: ORIC), and the Corporate Controller at MannKind Corporation, a public biopharmaceuticals company (NASDAQ: MNKD). Ms. Liao is a Certified Public Accountant in the state of California and a Chartered Global Management Accountant.

What is Carrie Liao's net worth?: The estimated net worth of Carrie Liao is at least $2.51 million as of March 25th, 2025. Ms. Liao owns 144,923 shares of Definium Therapeutics stock worth more than $2,514,414 as of February 10th. This net worth estimate does not reflect any other assets that Ms. Liao may own. Learn More about Carrie Liao's net worth.
How old is Carrie Liao?: Ms. Liao is currently 58 years old. There are 5 older executives and no younger executives at Definium Therapeutics. The oldest executive at Definium Therapeutics is Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D., Executive President, who is 71 years old. Learn More on Carrie Liao's age.
How do I contact Carrie Liao?: The corporate mailing address for Ms. Liao and other Definium Therapeutics executives is One World Trade Center Suite 8500 New York, NY 10007 United States. Definium Therapeutics can also be reached via phone at 212 220 6633 and via email at [email protected]. Learn More on Carrie Liao's contact information.
Has Carrie Liao been buying or selling shares of Definium Therapeutics?: Carrie Liao has not been actively trading shares of Definium Therapeutics in the last ninety days. Most recently, Carrie Liao sold 2,347 shares of the business's stock in a transaction on Tuesday, March 25th. The shares were sold at an average price of $6.74, for a transaction totalling $15,818.78. Following the completion of the sale, the chief accounting officer now directly owns 144,923 shares of the company's stock, valued at $976,781.02. Learn More on Carrie Liao's trading history.
Who are Definium Therapeutics' active insiders?: Definium Therapeutics' insider roster includes Robert Barrow (Chief Executive Officer and Board Director), Schond Greenway (CFO), David Gryska (Director), Dan Karlin (Insider), Daniel Karlin (Insider), Carrie Liao (CAO), and Mark Sullivan (Insider). Learn More on Definium Therapeutics' active insiders.
Are insiders buying or selling shares of Definium Therapeutics?: During the last twelve months, insiders at the sold shares 12 times. They sold a total of 163,667 shares worth more than $1,515,041.22. The most recent insider tranaction occured on December, 26th when insider Daniel Karlin sold 5,600 shares worth more than $73,640.00. Insiders at Definium Therapeutics own 2.3% of the company. Learn More about insider trades at Definium Therapeutics.
Information on this page was last updated on 12/26/2025.

Carrie Liao Insider Trading History at Definium Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/25/2025	Sell	2,347	$6.74	$15,818.78	144,923
12/26/2024	Sell	2,273	$7.43	$16,888.39	97,270
9/25/2024	Sell	2,352	$5.98	$14,064.96	99,543

Carrie Liao Buying and Selling Activity at Definium Therapeutics

Definium Therapeutics Company Overview

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Today's Range

Now: $17.35

$16.55

$17.40

50 Day Range

MA: $14.38

$11.94

$18.23

2 Week Range

Now: $17.35

$4.70

$18.70

Volume

829,525 shs

Average Volume

1,992,820 shs

Market Capitalization

$1.71 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57

Carrie Liao Biography and Net Worth

What is Carrie Liao's net worth?

How old is Carrie Liao?

How do I contact Carrie Liao?

Has Carrie Liao been buying or selling shares of Definium Therapeutics?

Who are Definium Therapeutics' active insiders?

Are insiders buying or selling shares of Definium Therapeutics?